Overall, they suggested that miR-520e plays a role in the regulation of HBV replication by inhibiting the p38MAPK and ERK1/2 signaling pathways through an inhibitory effect on EPHA2, ultimately reducing HBV replication and inhibiting tumor cell growth [57]. The gene discussed is EPHA2; the disease is neoplasm.